Guild: The AI trade is still in question despite the market rebound

Key Concepts

• Volatility: Fluctuations in market prices.
• VIX: A measure of implied volatility of S&P 500 index options, often referred to as the "fear index."
• AI Trade: Investments related to artificial intelligence technologies and companies.
• Dispersion: A divergence or spread between different economic or market segments.
• Wall Street Economy vs. Rest of the Economy: A perceived disconnect between financial markets and the broader economic reality.
• Neurocrine Biosciences (NBIX): A pharmaceutical company specializing in neurological disorders.
• Incresity: A drug developed by Neurocrine Biosciences.
• One Big Beautiful Bill: Likely referring to a significant piece of legislation supporting infrastructure or specific industries.
• Aerospace and Defense Industries: Sectors involved in aircraft manufacturing, space exploration, and military equipment.
• Capex: Capital expenditures, investments made by a company in its assets.
• Drones: Unmanned aerial vehicles.
• Midcap Space: Companies with market capitalizations between large-cap and small-cap companies.

Market Volatility and the AI Trade

The discussion begins by acknowledging recent volatility in the tech sector, particularly following Cororeweave's earnings. The speaker notes that volatility has been elevated for a while, with the VIX (volatility of volatility) expected to remain high throughout the year. A key concern is the ongoing uncertainty surrounding the returns on the AI trade, even after the resolution of a government shutdown that had caused some economic slowdown. The question of near-term profitability for AI investments remains open.

Dispersion: Two Economies

A central theme introduced is "dispersion," describing a growing divergence between the "Wall Street economy" (financial markets) and the "rest of the economy." This is likened to Europe post-2008, where a single currency and interest rate policy applied to countries experiencing vastly different economic conditions. This dispersion is observed not only in the overall economy but also within the market itself, with positive performance in certain "cheaper" or "smaller" tech names, pharmaceuticals, contrasting with questions surrounding the drivers of the recent bull market.

Investment Pick: Neurocrine Biosciences (NBIX)

The speaker's investment pick is Neurocrine Biosciences (NBIX), a niche pharmaceutical company focused on neurological disorders. It is held in Robin Hood Strategies portfolios.

• Valuation: The company is considered "pretty inexpensive," trading at approximately 22 times earnings.
• Quality and Growth: It is described as a high-quality company with consistent earnings.
• Underappreciated Pipeline: The appreciation of existing drugs and future pipeline, specifically mentioning Incresity, is believed to be underappreciated by the market.
• Micro vs. Macro Focus: The company's US-focused business model makes it less susceptible to broader macro-economic concerns.

Despite the healthcare sector generally benefiting from a supportive administration and anticipated rate cuts, Neurocrine Biosciences is seen as an underperformer that is "just getting started." The speaker believes the full impact of the current administration's focus on the pharmaceutical industry, supported by legislation like the "One Big Beautiful Bill," is yet to be realized.

Market Impact of Government Shutdown Resolution

With the potential end of a government shutdown, the discussion shifts to market segments likely to perform better.

• Healthcare: This sector has seen recent additions to portfolios, though this is not directly tied to the shutdown resolution.
• Consumer Names: Specific consumer companies that can perform well despite potential ongoing pressure are being added. TJ Maxx is cited as an example.
• Aerospace and Defense: The speaker anticipates renewed focus on this sector, supported by the "One Big Beautiful Bill" and potential government emphasis on capex.
• Financial Sector: This sector, which has been trading sideways, is also expected to benefit from a return to focus on other economic aspects.

Upside in Aerospace and Defense

The speaker expresses optimism about the aerospace and defense sectors, particularly in more niche areas. While acknowledging that large-cap names like GE Aerospace have already seen significant gains, there is expected to be more breadth in the sector.

• Midcap Value: The midcap space within aerospace and defense is seen as having more value to be had.
• Drones: Companies involved in drone technology, such as Kratos Defense and Security, are expected to benefit from increased drone deployment.
• Global Spending: Increased defense spending plans in both the US and Europe are identified as significant tailwinds.

Synthesis and Conclusion

The current market environment is characterized by significant volatility, particularly in the tech sector and the AI trade, alongside a growing "dispersion" between financial markets and the broader economy. This divergence creates opportunities in specific, often overlooked, segments. Neurocrine Biosciences is highlighted as an undervalued healthcare company with strong fundamentals and an underappreciated pipeline. The potential resolution of the government shutdown is expected to boost sectors like aerospace and defense, consumer discretionary, and financials, with particular optimism for midcap companies in the aerospace and defense space that are poised to benefit from increased global spending and technological advancements like drones. The overarching sentiment is that while broad market trends are uncertain, targeted investments in quality companies and specific growth areas can yield positive returns.